Treatment of superficial eye infections caused by bacteria
sensitive to polymyxin B and neomycin, based on susceptibility testing.

Qualitative and quantitative composition, Lyophilized, One 2 g vial
Contains active ingredients: Neomycin (sulfate)
……………………………………………………………17. 000
IU, Polymyxin B (sulfate)
………………………………………………………50. 000
UI, Excipients, Qualitative composition of excipients and others
Components: Disodium edetate, Dextran 70 for injections, Water
for injectable preparations,White to cream-colored powder.

Solvent, One 5 ml bottle contains, Excipients, Qualitative composition of
Excipients and other components, Benzalkonium Chloride 0,50 mg, Dextran 70
for injectable preparations, Sodium dihydrogen phosphate
dihydrate, Disodium phosphate dodecahydrate, Sodium chloride, Water for
injectable preparations, practically clear, colorless solution
practically free of particles.

Reconstituted solution, 1 ml
Contains active ingredients: Neomycin (sulfate)
……………………………………………………………..3.400
IU, Polymyxin B (sulfate)
………………………………………………….10. 000
UI, Excipients, Qualitative composition of excipients and others
components, Lyophilized, Disodium edetate, Dextran 70 for preparations
Injectables, Water for injections, Solvent, Benzalkonium chloride
0,10 mg, Dextran 70 for injections, Sodium dihydrogen phosphate
dihydrate, Disodium phosphate dodecahydrate, Sodium chloride, Water for
injectable preparations, practically clear, colorless to
light yellow in color and practically free of particles.

Species of
destination, Dogs and cats.